Immunophenotypically, these infiltrates express CD5-/+, CD103-, CD23-, and FMC7+, whereas abnormal B-cells in CLL typically express CD5+, CD23+, and FMC7-. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.